Synthetic CpG oligodeoxynucleotides accelerate the development of lupus nephritis during preactive phase in NZB ×NZWF1 mice

Abstract

The effect of synthetic CpG-oligodeoxynucleotides (CpG-ODN) on the development of lupus nephritis during preactive phase (within seven months of age) in autoimmune lupus NZB ×NZWF¹(B/WF₁) mice was examined. Treatment of CpG-ODN was started at the age of 2.75 months and continued until 6.25 months. Overt disease began at the age of six months and progressed linearly at the age of 6.75 months in CpG-ODN-treated, but not control ODN-treated (control) groups. Also compared to control group, CpG-ODN-treated mice exhibited a severe glomerulonephritis(GN), with prominent deposits of IgG2a and C3, which paralleled increased titre of IgG2a type anti-nuclear antibody in the blood. Among several cytokines (interleukin, IL-6, IL-4, IL-1a, IL-10, interferon-g and tumor necrosis factor-a) in blood, IL-6 production paralleled the developmentof lupus nephritis. The present study suggests that CpG-ODN may enhance IL-6 production. The role of IL-6 in the development of GN will be discussed.

Keywords

B/WF1 mouse CpG-ODN glomerulonephritis IL-6 preactive phase

Get full access to this article

View all access options for this article.

References

Lambert PH , Dixon FJ. Pathogenesis of the glomerulonephritis of NZB/W mice . J Exp Med 1968; 127: 507-522 .

Pisetsky DS. The antigenic properties of bacterial DNA in normal and aberrant immunity. A review . Springer Semin Immunopathol 2000; 22: 153-166 .

Tokado H , Yumura W , Shiota J , Hirose S , Sato H , Shirai T. Lupus nephritis in autoimmune-prone NZB ×NZWF1 mice and mechanisms of transition of the glomerular lesions . Acta Path Jpn 1991; 41: 1-11 .

Zeuner RA , Klinman DM , Illei G , Yarboro C , Ishii KJ , Gursel M et al. Response of peripheral blood mononuclear cell from lupus patients to stimulation by CpG oligodeoxynucleotides . Rheumatology 2003; 42: 563-569 .

Krieg AM.

CpG DNA: A pathogenic factor in systemic lupus erythematosus?

J Clin Immunol 1995; 15: 284-292 .

Sato Y , Miyata M , Nishimaki T , Kochi H , Kasukawa R. CpG motif-containing DNA fragments form sera of patients with systemic lupus erythematosus proliferate mononuclear cells in vitro . J Rheumatol 1999; 26: 294-301 .

Klinman DM , Yi AK , Beaucage SL , Comover J , Krieg AM. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon g . Proc Natl Acad Sci USA 1996; 93: 2879-2883 .

Pisetsky DS. Immune activation by bacterial DNA: a new genetic code. A review . Immunity 1996; 5: 303-310 .

Jacob T , Walker PS , Krieg AM , Udey MC , Vogel JC. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA . J Immunol 1998; 161: 3042-3049 .

10.

Sparwasser T , Koch ES , Vabulas RM , Heeg K , Lipford GB , Ellwart JW et al. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells . Eur J Immunol 1998; 28: 2045-2054 .

11.

Kranzer K , Bauer M , Lipford GB , Heeg K , Wagner H , Lang R. CpG-oligodeoxynucleotides enhance T-cell receptor-triggered interferon-gamma production and up-regulation of CD69 via induction of antigen-presenting cell-derived interferon type and interleukin-12 . Immunology 2000; 99: 170-178 .

12.

Hemmi H , Takeuchi O , Kawai T , Kaisho T , Sato S , Sanjo H et al. A toll-like receptor recognizes bacterial DNA . Nature 2000; 408: 740-745 .

13.

Gilkeson GS , Grudier JP , Karounous DG , Pisetsky DS. Induction of anti-double stranded DNA antibodies in normal mice by immunization with bacterial DNA . J Immunol 1989; 142: 1482-1486 .

14.

Pisetsky DS , Wenk KS , Reich CF III. The role of cpg sequences in the induction of anti-DNA antibodies . Clin Immunol 2001; 100: 157-163 .

15.

Akira S , Taga T , Kishimoto T. Interleukin-6 in biology and medicine . Adv Immunol 1993; 54: 1-78 .

16.

Lahat N , Aghai E , Maroun B , Kinarty A , Quitt M , Froom P. Increased spontaneous secretion of IL-6 from B cells of patients with B chronic lymphatic leukemia (B-CLL) and autoimmunity . Clin Exp Immunol 1991; 85: 302-306 .

17.

Walker PS , Scharton-Kersten T , Krieg AM , Love-Homan L , Rowton ED , Udey MC et al. Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-g-dependent mechanisms . Proc Natl Acad USA 1999; 96: 6970-6975 .

18.

Hayashi T , Yoshinaka K , Hasegawa K , Maeda K , Onodera T. CpG oligodeoxynucleotides accelerate reovirus type 2-triggered insulitis in DBA/1 suckling mice . Int J Exp Path 2002; 83: 217-223 .

19.

Kameyama Y , Hayashi T. Suppression of development of glomerulonephritis in NZB ×NZWF1 mice by persistent infection with lactic dehydrogenase virus: relations between intercellular adhesion molecule-1 expression on endothelial cells and leucocyte accumulation in glomeruli . Int J Exp Path 1994; 75: 295-304 .

20.

Hasegawa K , Hayashi T , Maeda K. Promotion of lupus in NZB ×NZWF1 mice by plasmids encoding interferon (IFN)-g but not by those encoding interleukin (IL)-4 . J Comp Path 2002; 127: 203-207 .

21.

Yamaguchi M , Manabe N , Uchio-Yamada K , Akashi N , Yamamoto Y , Ogura A et al. Localization of proliferative and apoptotic cells in the kidneys of ICR-derived glomerulonephritis (ICGN) mice . Anatomy 2001; 63: 781-787 .

22.

Miyata M , Ito O , Kobayashi H , Sasajima T , Ohira H , Suzuki S et al. CpG-DNA derived from sera in systemic lupus erythematosus enhances ICAM-1 expression on endothelial cells . Ann Rheum Dis 2001; 60: 685-689 .

23.

Hayashi T , Mori I , Yamamoto H. Lactic dehydrogenase virus infection prevents development of anti-nuclear antibody in (NZB ×NZW) F1mice; role of prostaglandin E2 and macrophage Ia expression . Int J Exp Path 1992; 73: 593-601 .

24.

Grondal G , Gunnarsson I , Ronnelid J , Rogberg S , Klareskog L , Lundberg I. Cytokine production, serum levels and disease activity in systemic lupus erythematosus . Clin Exp Rheumatol 2000; 18: 565-570 .

25.

Mihara M , Takagi N , Takeda Y , Ohsugi Y. IL-6 receptor blockage inhibits the onset of autoimmune kidney disease in NZB/W F1 mice . Clin Exp Immunol 1998; 112: 397-402 .

26.

Finck BK , Chan B , Wofsy D. Interleukin 6 promotes murine lupus in NZB/NZW F1 mice . J Clin Invest 1994; 94: 585-591 .

27.

Kacprzyk F. The importance of interleukin 6 (IL-6) in pathogenesis and diagnosis of renal glomerular diseases . Postepy Hig Med Dosw 1995; 49: 513-522 .

28.

Yu CL , Sun KH , Tsai CY , Hsieh SC , Yu HS.

Anti-dsDNA antibody up-regulates interleukin 6, but not cyclo-oxygenase, gene expression in glomerular mesangial cells: a marker of immune-mediated renal damage?

Inflamm Res 2001; 50: 12-18 .

29.

Amital H , Levi Y , Blank M , Barak V , Langevitz P , Afek A et al. Immunomodulation of murine experimental SLE-like disease by interferon-g . Lupus 1998; 7: 445-454 .

30.

Brennan DC , Yui MA , Wuthrich RP , Kelley VE. Tumor necrosis factor and IL-1 in New Zealand Black/White mice. Enhanced gene expression and acceleration of renal injury . J Immunol 1989; 143: 3470-3475 .

31.

Nakajima A , Hirose S , Yagita H , Okumura K. Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice . J Immunol 1997; 158: 1466-1472 .

32.

Sun KH , Yu CL , Tang SJ , Sun GH. Monoclonal anti-double-stranded DNA autoantibody stimulates the expression and release of IL-1b, IL-6, IL-8, IL-10 and TNF-a from normal human mononuclear cells involving in the lupus pathogenesis . Immunology 2000; 99: 352-360 .

33.

Lawson BR , Prud’homme GJ , Chang Y , Gardner HA , Kuan J , Kono DH et al. Treatment of murine lupus with cDNA encoding IFN-gR/Fc . J Clin Invest 2000; 106: 207-215 .